• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Retifanlimab Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5819101

Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Retifanlimab, Monoclonal Antibody
Full Product Name
Retifanlimab
Clonality
Monoclonal
Species Reactivity
Programmed cell death protein 1 (PD-1)
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
2079108-44-2

Other Notes

Small volumes of anti-Retifanlimab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Retifanlimab purchase

MBS5819101 is an antibody targeting Retifanlimab. Reactive in Programmed cell death protein 1 (PD-1).
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000